Stephen Poor

Company: Novartis

Job title: Executive Director & Head of Global Program Clinical

Seminars:

Developing Novel Imaging Regulatory Decision-Enabling Endpoints for Clinical Validation 1:40 pm

Most optometric instruments are designed to assess vision to achieve functional endpoints and efficacy. To better understand the structure-function relationship and create more reliable assessments, imaging endpoints are being developed. This workshop will dive into how the criteria for getting approval for imaging endpoints in the clinic. In this session, you will: Find efficacy on…Read more

day: Pre-Conference Workshop Day

Panel Discussion: Improving Patient Care with the Help of Personalised Medicine Through AI for the Diagnosis & Optimization of the Right Patients for Clinical Trials 9:30 am

Understanding characteristics of retinal imaging and artificial intelligence that may help identify the right patients for clinical trials Utilizing different imaging tools for treatment and management of patients – different imaging modalities and which ones are more appropriate for different Ophthalmic disease states Using AI to improve patient care by sequencing data and linking imaging…Read more

day: Conference Day Two